Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine for paravertebral block in thoracoscopic partial lung resection
ChiCTR2300075634Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in lung neoplasm (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Visual Analog Scale (VAS) score. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
lung neoplasm
Beyond the preview
Go deeper on ChiCTR2300075634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075634.